TSPAN7
Tetraspanin-7
Also known as: A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2, TSN7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P41732
- Gene
- TSPAN7
- Ensembl
- ENSG00000156298
- Chromosome
- X
- Canonical length
- 249 aa
- Protein class
- CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein and may have a role in the control of neurite outgrowth. It is known to complex with integrins. This gene is associated with X-linked cognitive disability and neuropsychiatric diseases such as Huntington's chorea, fragile X syndrome and myotonic dystrophy. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
249 residues, UniProt reviewed canonical sequence.
>P41732|TSPAN7
1 MASRRMETKP VITCLKTLLI IYSFVFWITG VILLAVGVWG KLTLGTYISL IAENSTNAPY
61 VLIGTGTTIV VFGLFGCFAT CRGSPWMLKL YAMFLSLVFL AELVAGISGF VFRHEIKDTF
121 LRTYTDAMQT YNGNDERSRA VDHVQRSLSC CGVQNYTNWS TSPYFLEHGI PPSCCMNETD
181 CNPQDLHNLT VAATKVNQKG CYDLVTSFME TNMGIIAGVA FGIAFSQLIG MLLACCLSRF
241 ITANQYEMVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TSPAN7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 677 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 677 nTPM
- basal ganglia: 653 nTPM
- cerebellum: 510 nTPM
- amygdala: 387 nTPM
- hippocampal formation: 335 nTPM
- hypothalamus: 271 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 433 nCPM
- brain inhibitory neurons: 320 nCPM
- brain excitatory neurons: 284 nCPM
- astrocytes: 252 nCPM
- vascular endothelial cells: 250 nCPM
- myonuclei: 222 nCPM
Immune cell
- memory CD8 T-cell: 0.6 nTPM
- naive CD4 T-cell: 0.3 nTPM
- naive CD8 T-cell: 0.2 nTPM
- memory CD4 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebral cortex: 717 nTPM
- basal ganglia: 504 nTPM
- hippocampal formation: 441 nTPM
- white matter: 390 nTPM
- cerebellum: 370 nTPM
- hypothalamus: 299 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TSPAN7.
Disease | AllUniProt
Conditions TSPAN7 is implicated in, by any mechanism.
- Intellectual developmental disorder, X-linked 58 (XLID58) MIM:300210
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 114 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual disability, X-linked 58
- Lung cancer
- Thyroid cancer, nonmedullary, 1
Disease | ImmuneIEDB
Conditions an epitope on TSPAN7 was assayed in.
- lung adenocarcinoma T cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against TSPAN7 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for TSPAN7 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Tetraspanin 7 autoantibodies in type 1 diabetes.
2016 · Diabetologia · RCR 1.3 · 36 citations - Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA.
2019 · Diabetologia · RCR 0.9 · 22 citations - Cytoplasmic ends of tetraspanin 7 harbour epitopes recognised by autoantibodies in type 1 diabetes.
2019 · Diabetologia · RCR 0.4 · 8 citations - Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
2020 · Endocr J · RCR 0.2 · 3 citations - [The establishment and application of testing methods of tetraspanin 7 autoantibody in type 1 diabetes].
2021 · Zhonghua Yi Xue Za Zhi · RCR 0.1 · 1 citations
Reference: T cellIEDB
1 publication
- In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma.
2024 · Front Immunol · RCR 0.1 · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0.75
- gnomAD missense Z
- 1.91
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TSPAN7 as an antibody target. Whether an autoantibody or antibody against TSPAN7 could matter depends on whether native TSPAN7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TSPAN7 is annotated at the cell surface, where native TSPAN7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TSPAN7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...